Tirzepatide 30Mg
Tirzepatide is a dual-action metabolic peptide that activates both GLP-1 and GIP receptors to support appetite control, improved glucose metabolism, and weight management. By enhancing insulin response and increasing satiety, tirzepatide helps regulate blood sugar levels while promoting fat loss and overall metabolic health.
Product Usage: For Research Use Only – Not for Human or Veterinary Use
This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated or approved by the FDA. It is strictly intended for in vitro laboratory research by qualified professionals. Any use in humans or animals is expressly prohibited and may violate federal, state, or local regulations, including the Federal Food, Drug, and Cosmetic Act. No therapeutic or diagnostic applications are implied or authorized. The purchaser assumes full responsibility for compliance with all applicable laws. By purchasing this product, the buyer represents and warrants that it will be used exclusively for in vitro research and acknowledges that AION PEPTIDES enforces strict internal policies to ensure all sales remain designated for research use only.
Product Name:
Tirzepatide
Chemical Information:
Chemical Name: Dual GIP/GLP-1 receptor agonist peptide
Molecular Formula: C225H348N48O68
Molecular Weight: ~4813.5 Da
Compound Class: Synthetic dual incretin receptor agonist
Molecular Structure:
Description:
Engineered peptide acting on both GIP and GLP-1 receptors, designed for prolonged activity and metabolic pathway modulation.
Research Applications:
- Dual incretin pathway research
- Glucose homeostasis studies
- Weight regulation models
- Metabolic disease research
Storage and Handling:
Store at -20°C. Protect from light and moisture. Avoid repeated freeze-thaw cycles.
Product Specifications:
Purity: ≥99% (HPLC Certified)
Appearance: White to off-white lyophilized powder
Solubility: Soluble in sterile water
